**********************Anthropic $30B ARR > OpenAI $25B + $2B secondary + Chinese copying + Q1 $253B VC**********************
Key Questions
Has Anthropic surpassed OpenAI in revenue?
Yes, Anthropic has reached $30B ARR, tripling year-over-year, compared to OpenAI's $25B ARR. This positions Anthropic ahead in the AI revenue race.
What are the key factors driving Anthropic's revenue growth?
Anthropic's $30B ARR is fueled by over 1,000 customers spending $1M each, Claude Code generating $2.5B, and 3.5GW of compute capacity. The company has seen rapid expansion with strong enterprise adoption.
What happened to OpenAI's valuation on the secondary market?
OpenAI's secondary market valuation dropped from $852B to $765B amid sinking demand, with only $2B in secondary interest. In contrast, demand for Anthropic shares is running hot.
What biotech acquisition did Anthropic recently make?
Anthropic acquired AI-driven biotech startup Coefficient Bio for approximately $400 million in stock. This move supports diversification amid Anthropic's $380B valuation.
What record was set in North American VC funding for AI in Q1?
North American VC funding hit a record $253B in Q1, with AI startups raising nearly $300B overall, led by major players like OpenAI, Anthropic, and Waymo. This reflects a surge in early-stage and high-risk AI investments.
What funding did Chinese robotics startup Galaxea AI secure?
Galaxea AI raised $290M in a Series B+ round, achieving a $29B valuation. The Beijing-based company focuses on embodied AI with Vision-Language-Action models.
What is the latest on Indian AI startup Sarvam AI?
Sarvam AI raised $350M, reaching unicorn status with a $1.55B valuation. The funding aims to develop localized AI models for India.
What media acquisition did OpenAI announce?
OpenAI acquired TBPN, an online tech-industry talk show competing with Bloomberg and CNBC. This is part of a trend toward creator and media acquisitions in the AI era.
Anthropic $30B ARR (tripled YoY, 1K+ $1M customers, Claude Code $2.5B, 3.5GW compute) leapfrogs OpenAI $25B vs $2B secondary demand/OpenAI drop to $765B (from $852B); $400M AI biotech acq amid $380B val/Claude leak; Q1 NA VC $253B record; Chinese (Galaxea $290M B+ $29B robotics, Sarvam $350M $1.55B unicorn)/DeepSeek copying; TBPN buy (Apr13-23). Turf war + diversification + India/China surges.